Osimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLCDavid Planchard, Kunihiko Kobayashi, Pasi A. Jänne et al.|New England Journal of Medicine|2023Cited by 695
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trialBradley J. Monk, Jyoti Mayadev, R. Tarnawski et al.|The Lancet Oncology|2023Cited by 214